338 related articles for article (PubMed ID: 9129464)
1. Peculiar body composition in patients with Prader-Labhart-Willi syndrome.
Brambilla P; Bosio L; Manzoni P; Pietrobelli A; Beccaria L; Chiumello G
Am J Clin Nutr; 1997 May; 65(5):1369-74. PubMed ID: 9129464
[TBL] [Abstract][Full Text] [Related]
2. Update on body composition and bone density in children with Prader-Willi syndrome.
Rubin DA; Cano-Sokoloff N; Castner DL; Judelson DA; Wright P; Duran A; Haqq AM
Horm Res Paediatr; 2013; 79(5):271-6. PubMed ID: 23615452
[TBL] [Abstract][Full Text] [Related]
3. Body composition and fatness patterns in Prader-Willi syndrome: comparison with simple obesity.
Theodoro MF; Talebizadeh Z; Butler MG
Obesity (Silver Spring); 2006 Oct; 14(10):1685-90. PubMed ID: 17062796
[TBL] [Abstract][Full Text] [Related]
4. Relative Contributions of Lean and Fat Mass to Bone Mineral Density: Insight From Prader-Willi Syndrome.
Viardot A; Purtell L; Nguyen TV; Campbell LV
Front Endocrinol (Lausanne); 2018; 9():480. PubMed ID: 30186239
[No Abstract] [Full Text] [Related]
5. Anthropometric adjustments are helpful in the interpretation of BMD and BMC Z-scores of pediatric patients with Prader-Willi syndrome.
Hangartner TN; Short DF; Eldar-Geva T; Hirsch HJ; Tiomkin M; Zimran A; Gross-Tsur V
Osteoporos Int; 2016 Dec; 27(12):3457-3464. PubMed ID: 27377921
[TBL] [Abstract][Full Text] [Related]
6. Sustained benefits of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome are dose-dependent.
Carrel AL; Myers SE; Whitman BY; Allen DB
J Pediatr Endocrinol Metab; 2001; 14(8):1097-105. PubMed ID: 11592566
[TBL] [Abstract][Full Text] [Related]
7. Body composition in Prader-Willi syndrome compared with nonsyndromal obesity: Relationship to physical activity and growth hormone function.
van Mil EG; Westerterp KR; Gerver WJ; Van Marken Lichtenbelt WD; Kester AD; Saris WH
J Pediatr; 2001 Nov; 139(5):708-14. PubMed ID: 11713451
[TBL] [Abstract][Full Text] [Related]
8. Comparison of body composition, basal metabolic rate and metabolic outcomes of adults with Prader Willi syndrome or lesional hypothalamic disease, with primary obesity.
Lloret-Linares C; Faucher P; Coupaye M; Alili R; Green A; Basdevant A; Clément K; Poitou C
Int J Obes (Lond); 2013 Sep; 37(9):1198-203. PubMed ID: 23318724
[TBL] [Abstract][Full Text] [Related]
9. Influence of body composition on bone mineral content in children and adolescents.
Manzoni P; Brambilla P; Pietrobelli A; Beccaria L; Bianchessi A; Mora S; Chiumello G
Am J Clin Nutr; 1996 Oct; 64(4):603-7. PubMed ID: 8839506
[TBL] [Abstract][Full Text] [Related]
10. Does segmental body composition differ in women with Prader-Willi syndrome compared to women with essential obesity?
Bedogni G; Grugni G; Tringali G; Marazzi N; Sartorio A
J Endocrinol Invest; 2015 Sep; 38(9):957-61. PubMed ID: 25840793
[TBL] [Abstract][Full Text] [Related]
11. Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome.
Myers SE; Carrel AL; Whitman BY; Allen DB
J Pediatr; 2000 Jul; 137(1):42-9. PubMed ID: 10891820
[TBL] [Abstract][Full Text] [Related]
12. Body composition during GH treatment in Prader-Labhardt-Willi syndrome.
Bosio L; Beccaria L; Benzi F; Sanzari A; Chiumello G
J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():351-3. PubMed ID: 10698601
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptor (AR) gene CAG trinucleotide repeat length associated with body composition measures in non-syndromic obese, non-obese and Prader-Willi syndrome individuals.
Butler MG; Manzardo AM
J Assist Reprod Genet; 2015 Jun; 32(6):909-15. PubMed ID: 25925349
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance and obesity-related factors in Prader-Willi syndrome: comparison with obese subjects.
Talebizadeh Z; Butler MG
Clin Genet; 2005 Mar; 67(3):230-9. PubMed ID: 15691361
[TBL] [Abstract][Full Text] [Related]
15. In adults with Prader-Willi syndrome, elevated ghrelin levels are more consistent with hyperphagia than high PYY and GLP-1 levels.
Purtell L; Sze L; Loughnan G; Smith E; Herzog H; Sainsbury A; Steinbeck K; Campbell LV; Viardot A
Neuropeptides; 2011 Aug; 45(4):301-7. PubMed ID: 21722955
[TBL] [Abstract][Full Text] [Related]
16. Reduced bone mineral density and increased bone turnover in Prader-Willi syndrome compared with controls matched for sex and body mass index--a cross-sectional study.
Vestergaard P; Kristensen K; Bruun JM; Østergaard JR; Heickendorff L; Mosekilde L; Richelsen B
J Pediatr; 2004 May; 144(5):614-9. PubMed ID: 15126995
[TBL] [Abstract][Full Text] [Related]
17. Muscle-bone characteristics in children with Prader-Willi syndrome.
Edouard T; Deal C; Van Vliet G; Gaulin N; Moreau A; Rauch F; Alos N
J Clin Endocrinol Metab; 2012 Feb; 97(2):E275-81. PubMed ID: 22162467
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone treatment improves body composition in adults with Prader-Willi syndrome.
Höybye C; Hilding A; Jacobsson H; Thorén M
Clin Endocrinol (Oxf); 2003 May; 58(5):653-61. PubMed ID: 12699450
[TBL] [Abstract][Full Text] [Related]
19. Prader-Willi syndrome is associated with activation of the innate immune system independently of central adiposity and insulin resistance.
Viardot A; Sze L; Purtell L; Sainsbury A; Loughnan G; Smith E; Herzog H; Steinbeck K; Campbell LV
J Clin Endocrinol Metab; 2010 Jul; 95(7):3392-9. PubMed ID: 20444923
[TBL] [Abstract][Full Text] [Related]
20. Benefits of long-term GH therapy in Prader-Willi syndrome: a 4-year study.
Carrel AL; Myers SE; Whitman BY; Allen DB
J Clin Endocrinol Metab; 2002 Apr; 87(4):1581-5. PubMed ID: 11932286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
